メタ情報
| meta description平均長 | 0 |
|---|
| OGPありページ数 | 0 |
|---|
| Twitterカードありページ数 | 0 |
|---|
HTML言語 分布
| キー | 割合 |
|---|
| zh-tw | 65.00% |
| en-us | 20.00% |
| ja-jp | 10.00% |
| en | 5.00% |
内部リンク分析（Internal）
| ユニーク内部リンク数 | 64 |
|---|
| ページあたり内部リンク平均 | 25.2 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| Liu | 1 |
| development | 1 |
| Libo | 0.833333 |
| Corp | 0.666667 |
| management | 0.666667 |
| University | 0.666667 |
| Tsai | 0.666667 |
| Henry | 0.5 |
| Pharma | 0.5 |
| company | 0.5 |
| Before | 0.5 |
| business | 0.5 |
| his | 0.5 |
| Mandy | 0.5 |
| Lee | 0.5 |
| was | 0.5 |
| Director | 0.5 |
| Business | 0.5 |
| technology | 0.5 |
| programs | 0.5 |
| vaccine | 0.5 |
| MSD | 0.5 |
| manufacturing | 0.5 |
| process | 0.5 |
| can | 0.456357 |
| CEO | 0.333333 |
| leading | 0.333333 |
| Prior | 0.333333 |
| Sciences | 0.333333 |
| LLSC | 0.333333 |
| Executive | 0.333333 |
| responsibilities | 0.333333 |
| several | 0.333333 |
| research | 0.333333 |
| received | 0.333333 |
| MSc | 0.333333 |
| also | 0.333333 |
| Development | 0.333333 |
| responsible | 0.333333 |
| strategic | 0.333333 |
| she | 0.333333 |
| BOEHMERT | 0.333333 |
| years | 0.333333 |
| commercialization | 0.333333 |
| commercial | 0.333333 |
| end | 0.333333 |
| 9F | 0.25 |
| Nanjing | 0.25 |
| Datong | 0.25 |
| Dist | 0.25 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Monday | com | 2.637109 | 16 |
| libo | mail | 2.441005 | 16 |
| libo | libopharma | 2.441005 | 16 |
| com | libopharma | 2.441005 | 16 |
| Friday | Monday | 2.354817 | 12 |
| Lee | Mandy | 2.238966 | 12 |
| 9F | Nanjing | 2.238966 | 12 |
| Datong | Nanjing | 2.238966 | 12 |
| Datong | Dist | 2.238966 | 12 |
| Dist | Taipei | 2.238966 | 12 |
| City | Taipei | 2.238966 | 12 |
| 9F | Address | 2.191825 | 12 |
| Friday | com | 2.191825 | 12 |
| Libo | Pharma | 2.090216 | 13 |
| Perhaps | looking | 2.072053 | 8 |
| Corp | Pharma | 2.028834 | 12 |
| City | Taiwan | 2.028834 | 12 |
| 公司主旨專注於開發臨床市場未被滿足之需求 | 麗寶新藥成立於2017年01月 | 2.005984 | 8 |
| 合作聯盟模式 | 透過高度聯結來 | 2.005984 | 8 |
| Monday | libopharma | 1.981693 | 12 |
| 10am | Friday | 1.969781 | 8 |
| unmet | 公司主旨專注於開發臨床市場未被滿足之需求 | 1.946882 | 8 |
| need | unmet | 1.946882 | 8 |
| need | 的新型藥物 | 1.946882 | 8 |
| 的新型藥物 | 麗寶新藥營運模式採取聯合模組協同開發 | 1.946882 | 8 |
| 將企業本體作為一個管理與核心技能 | 麗寶新藥營運模式採取聯合模組協同開發 | 1.946882 | 8 |
| core | 將企業本體作為一個管理與核心技能 | 1.946882 | 8 |
| competency | core | 1.946882 | 8 |
| competency | 發展中心 | 1.946882 | 8 |
| 並於營運時期的不同階段 | 採取 | 1.946882 | 8 |
| 外部資源委託 | 採取 | 1.946882 | 8 |
| 合作執行模式 | 外部資源委託 | 1.946882 | 8 |
| 合作執行模式 | 權利授權模式 | 1.946882 | 8 |
| 合作聯盟模式 | 權利授權模式 | 1.946882 | 8 |
| find | what | 1.946882 | 8 |
| what | you | 1.946882 | 8 |
| looking | you | 1.946882 | 8 |
| can | seems | 1.883311 | 8 |
| 分散風險 | 透過高度聯結來 | 1.881872 | 7 |
| Taiwan | mail | 1.818701 | 12 |
| libopharma | mail | 1.818701 | 12 |
| com | libo | 1.818701 | 12 |
| Perhaps | searching | 1.812772 | 6 |
| 10am | Monday | 1.808408 | 8 |
| can | find | 1.75814 | 8 |
| 分散風險 | 活化資金流動 | 1.741432 | 6 |
| Henry | Liu | 1.732669 | 12 |
| Business | Development | 1.719439 | 8 |
| commercial | manufacturing | 1.719439 | 8 |
| looking | searching | 1.709503 | 6 |